Login / Signup

Detecting disability using self-reported and clinical assessments in early-stage relapsing-remitting multiple sclerosis: Looking for a complementary approach.

Susana Sainz de la MazaRocío Gómez-BallesterosMónica BorgesJesús Martín-MartínezJavier SotocaA M Alonso TorresAna B CamineroLaura BorregaJosé L Sánchez-MenoyoFrancisco J Barrero-HernándezCarmen CallesLuis BrievaMaría R Blasco-QuílezJulio Dotor García-SotoMaría Del Campo-AmigoLaura Navarro-CantóEduardo AgüeraMoisés Garcés-RedondoOlga CarmonaLaura Gabaldón-TorresLucía ForeroMariona HervàsNicolás MedranoJorge MaurinoTamara Castillo Triviño
Published in: Multiple sclerosis journal - experimental, translational and clinical (2023)
Disability accrual is mainly driven by progression independent of relapse activity, which is present even in early stages of relapsing-remitting multiple sclerosis (RRMS) and sometimes overlooked. This multicenter, non-interventional study evaluated whether patient-reported outcomes measures (PROMs) could capture disability in 189 early-stage RRMS patients (mean age: 36.1 ± 9.4 years, 71.4% female, mean disease duration: 1.4 ± 0.8 years, median EDSS: 1.0). The 9-Hole Peg Test (9-HPT), NeuroQoL Upper Extremity (NeuroQoL-UE), Timed 25-Foot Walk (T25-FW), Multiple Sclerosis Walking Scale (MSWS-12), Symbol Digit Modalities Test (SDMT), and Perceived Deficits Questionnaire (PDQ-5) were used to assess hand function, gait, and cognition, respectively. These functions were at least mildly affected in this early-stage population, finding significant correlations between PROMs and clinical assessments. PROMs could enable early-stage RRMS patients to communicate their perceived disability in different domains, assisting clinicians in disease monitoring and decision making.
Keyphrases